SCHEMBL1663988

SCHEMBL1663988

O=C(O)C1C2CC(C3OC23)C1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
POLB P06746 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 2/20 0.44
GMNN O75496 1/20 0.44
LMNA P02545 1/20 0.44
PMP22 Q01453 1/20 0.44
TFPI2 P48307 1/20 0.44
TP53 P04637 1/20 0.44
NFKB1 P19838 1/20 0.44
THPO P40225 1/20 0.44
PPP5C P53041 2/20 0.43
MAPK1 P28482 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.35
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33
APEX1 P27695 1/20 0.33
PPP1CC P36873 1/20 0.33
GRM8 O00222 2/20 0.32
GRM2 Q14416 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548489 0.84 PPP5C (0.46) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL1663194 0.84 TFPI2 (0.50) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL3425859 0.80 POLB (0.52) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL432536 0.80 POLB (0.57) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL29426398 0.78 POLB (0.50) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL16361417 0.76 POLB (0.48) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL1548347 0.75 POLB (0.42) POLBTDP1GRM2GRM4ALDH1A1
SCHEMBL23214101 0.74 POLB (0.46) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL15796345 0.74 TSHR (0.68) TSHRPOLBTDP1KDM4EGMNN
SCHEMBL8978055 0.74 POLB (0.57) TSHRPOLBTDP1KDM4EGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170153549-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION HAVING ORGANIC GROUP HAVING ALIPHATIC POLYCYCLIC STRUCTURE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-06-01 US disclosed
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC TSHR 4543/4885POLB 582/4885TDP1 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.